Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.15 - $1.48 $44,923 - $57,814
-39,064 Reduced 12.62%
270,452 $346,000
Q4 2023

Feb 14, 2024

SELL
$1.22 - $1.62 $22,446 - $29,806
-18,399 Reduced 5.61%
309,516 $420,000
Q3 2023

Nov 14, 2023

BUY
$0.98 - $1.62 $41,212 - $68,127
42,054 Added 14.71%
327,915 $504,000
Q2 2023

Aug 14, 2023

SELL
$0.58 - $1.31 $27,339 - $61,749
-47,137 Reduced 14.16%
285,861 $271,000
Q1 2023

May 15, 2023

BUY
$0.76 - $1.82 $11,511 - $27,567
15,147 Added 4.77%
332,998 $332,000
Q4 2022

Feb 14, 2023

SELL
$0.64 - $0.91 $47,854 - $68,043
-74,773 Reduced 19.04%
317,851 $225,000
Q3 2022

Nov 14, 2022

SELL
$0.68 - $1.11 $55,093 - $89,932
-81,020 Reduced 17.11%
392,624 $252,000
Q2 2022

Aug 15, 2022

SELL
$0.75 - $1.33 $149,091 - $264,389
-198,789 Reduced 29.56%
473,644 $436,000
Q1 2022

May 16, 2022

BUY
$1.29 - $4.04 $258,643 - $810,015
200,499 Added 42.48%
672,433 $888,000
Q4 2021

Feb 14, 2022

BUY
$3.45 - $6.05 $499,166 - $875,350
144,686 Added 44.21%
471,934 $1.82 Million
Q3 2021

Nov 15, 2021

BUY
$5.53 - $9.28 $1.14 Million - $1.91 Million
205,800 Added 169.46%
327,248 $1.83 Million
Q2 2021

Aug 16, 2021

BUY
$7.84 - $12.6 $12,363 - $19,870
1,577 Added 1.32%
121,448 $1.08 Million
Q1 2021

May 17, 2021

BUY
$10.54 - $19.3 $279,215 - $511,276
26,491 Added 28.37%
119,871 $1.52 Million
Q4 2020

Feb 16, 2021

BUY
$12.79 - $17.1 $1.03 Million - $1.38 Million
80,438 Added 621.53%
93,380 $1.3 Million
Q3 2020

Nov 16, 2020

SELL
$12.99 - $19.41 $687,443 - $1.03 Million
-52,921 Reduced 80.35%
12,942 $169,000
Q2 2020

Aug 14, 2020

BUY
$12.19 - $22.96 $802,869 - $1.51 Million
65,863 New
65,863 $1.15 Million
Q1 2020

May 15, 2020

SELL
$10.08 - $27.21 $378,010 - $1.02 Million
-37,501 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$13.05 - $21.88 $489,388 - $820,521
37,501 New
37,501 $755,000

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0

About AVROBIO, Inc.


  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.